Abstract:Background: Lung cancer is the most common primary malignant tumor of the lung, and as one of the malignant tumors that pose the greatest threat to the health of the population, the incidence rate has remained high in recent years. Previous studies have shown that KLRB1 is transcriptionally repressed in lung adenocarcinoma and correlates with lung adenocarcinoma prognosis. The objective of this study is to investigate the intrinsic mechanisms by which KLRB1 affects the malignant phenotypes of lung adenocarcinoma such as immune infiltration, proliferation, growth and metastasis. Methods: We assessed the expression levels of KLRB1 in publicly available databases and investigated its associations with clinical and pathological variables. Enrichment analysis was subsequently conducted to investigate possible signaling pathways and their associated biological functions. Statistical analysis, including Spearman correlation and the application of multigene prediction models, was utilized to assess the relationship between the expression of KLRB1 and the infiltration of immune cells. The diagnostic and prognostic value of KLRB1 was evaluated using Kaplan-Meier survival curves, diagnostic receptor operating characteristic (ROC) curves, histogram models, and Cox regression analysis. Specimens from lung adenocarcinoma (LUAD) patients were collected, the expression level of KLRB1 was detected by protein blotting analysis, and the expression level of KLRB1 was detected at the mRNA level by real-time quantitative reverse transcription polymerase chain reaction (RT-qPCR). Small interfering RNA (siRNA) was used to silence gene expression, and Transwell, Cell Counting Kit-8 (CCK-8) and colony formation assays were subsequently performed to analyze the effects of KLRB1 on LUAD cell migration, invasion and proliferation. Results: KLRB1 expression was lower in lung cancer tissue than in surrounding healthy tissue. Genes differentially expressed in the low and high KLRB1 expression groups were found to be significantly enriched in pathways related to immunity. KLRB1 exerted an impact on the MAPK/ERK signaling pathway, thereby modulating the growth and proliferation of LUAD cells. KLRB1 expression is linked to prognosis, immune infiltration, and cell migration and proliferation in LUAD. Conclusions: The evidence revealed a correlation between KLRB1 and both prognosis and immune infiltration in LUAD patients.

CBLL1 is Highly Expressed in Non‐small Cell Lung Cancer and Promotes Cell Proliferation and Invasion

Epigenetic Downregulated ITGBL1 Promotes Non-Small Cell Lung Cancer Cell Invasion Through Wnt/PCP Signaling

FBXO25 Promotes Cell Proliferation, Invasion, and Migration of NSCLC

CBX8 Promotes Epithelial-mesenchymal Transition, Migration, and Invasion of Lung Cancer through Wnt/β-catenin Signaling Pathway

CBLC promotes the development of colorectal cancer by promoting ABI1 degradation to activate the ERK signaling pathway

Bmi-1 Expression Modulates Non-Small Cell Lung Cancer Progression.

[Expression and Clinical Significance of BCL6 Corepressor-Like 1 in Non-Small Cell Lung Cancer].

LINC00514 facilitates cell proliferation, migration, invasion, and epithelial-mesenchymal transition in non-small cell lung cancer by acting on the Wnt/β-catenin signaling pathway

Overexpression of HN1L promotes cell malignant proliferation in non-small cell lung cancer.

Novel Long Non-Coding RNA LBX2-AS1 Indicates Poor Prognosis and Promotes Cell Proliferation and Metastasis Through Notch Signaling in Non-Small Cell Lung Cancer.

XBP1- IGFBP3 Signaling Pathway Promotes NSCLC Invasion and Metastasis

C1q-like 1 is frequently up-regulated in lung adenocarcinoma and contributes to the proliferation and invasion of tumor cells

Mll1 Promotes Cervical Carcinoma Cell Tumorigenesis and Metastasis Through Interaction with Beta-Catenin

Cx31.1 acts as a tumour suppressor in non-small cell lung cancer (NSCLC) cell lines through inhibition of cell proliferation and metastasis.

LncRNA BX357664 Inhibits the Proliferation and Invasion of Non-Small Cell Lung Cancer Cells.

BUB1 induces AKT/mTOR pathway activity to promote EMT induction in human small cell lung cancer

TBLR1 is a Novel Prognostic Marker and Promotes Epithelial–mesenchymal Transition in Cervical Cancer

NCBP1 promotes the development of lung adenocarcinoma through up-regulation of CUL4B.

Β-Catenin Cooperates with CREB Binding Protein to Promote the Growth of Tumor Cells

KLRB1 expression is associated with lung adenocarcinoma prognosis and immune infiltration and regulates lung adenocarcinoma cell proliferation and metastasis through the MAPK/ERK pathway

Low expression of BTN3A3 indicates poor prognosis and promotes cell proliferation, migration and invasion in non-small cell lung cancer